Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva

Cancer

Volumn 78, Issue 2, 1996, Pages 273-277

  Tempfer, Clemens ^a   Gitsch, Gerald ^a   Haeusler, Guenther ^a   Reinthaller, Alexander ^a   Koelbl, Heinz ^a   Kainz, Christian ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

adhesion molecules; prognosis; vulvar carcinoma

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; EXONS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; ISOANTIGENS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SEQUENCE ANALYSIS; SURVIVAL RATE; VULVAR NEOPLASMS;

EID: 0029680163     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960715)78:2<273::AID-CNCR13>3.0.CO;2-T     Document Type: Article

References (19)

1. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994;10:31-46.
2. Corn BW, Lanciano RM. Combined modality treatment for carcinomas of the uterine cervix and vulva. Curr Opin Oncol 1994;6:524-30.
3. Wahlen SA, Slater JD, Wagner RJ, Wang WA, Keeney ED, Hocko JM, et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer 1995;75:2289-94.
4. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-4.
5. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991;10:343-8.
6. Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A. CD44 contributes to T cell activation. J Immunol 1989;143:798-801.
7. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340:1053-8.
8. Smith CW, Patton JG, Nadal Ginard B. Alternative splicing in the control of gene expression. Annu Rev Genet 1989; 23:527-77.
9. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995;345:615-9.
10. Heider KH, Dammrich J, Skroch Angel P, Muller Hermelink HK, Vollmers HP, Herrlich P, et al. Differential expression of CD44 splice variants in intestinal-and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993;53:4197-203.
11. Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344:1470-2.
12. Joensuu H, Ristamaki R, Klemi PJ, Jalkanen S. Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Br J Cancer 1993;68:428-32.
13. Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, et al. Splice Variants of CD44 in Human Cervical Cancer Stage IB to IIB. Gynecol Oncol 1995;57:383-7.
14. Herrlich P, Zoller M, Pals ST, Ponta H. CD44 splice variants: metastases meet lymphocytes. Immunol Today 1993; 14:395-9.
15. Cannistra SA, Abu-Jawdeh G, Niloff J. CD44 Variant Expression is a common feature of epithelial ovarian cancer: Lack of association with standard prognostic factors. J Clin Oncol 1995;13:1912-21.
16. Hermanek P, Sobin L. UICC TNM Classification of malignant tumours. 4th ed. 2nd rev. Berlin: Springer-Verlag, 1992.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Salmi M, Gron Virta K, Sointu P, Greman R, Kalimo H, Jalkanen S. Regulated Expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993;122:431-42.
19. Dall P, Heider KH, Sinn HP, Skroch Angel P, Adolf G, Kauffmann M, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 1995;60: 471-7.